EP1910353 - TRICYCLIC DELTA- OPIOID MODULATORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.07.2012 Database last updated on 13.11.2024 | Most recent event Tooltip | 06.07.2012 | Application deemed to be withdrawn | published on 08.08.2012 [2012/32] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [2008/16] | Inventor(s) | 01 /
DAX, Scott, L. 3 Quail Drive Landenberg, PA 19350 / US | 02 /
DECORTE, Bart 1590 Winding Road Southhampton, PA 18966 / US | 03 /
LIU, Li 271 Fox Chase Lane Doylestown, PA 18901 / US | 04 /
MCDONNELL, Mark 1280 Sumneytown Pike Lansdale, PA 19446 / US | 05 /
MCNALLY, James, J. 321 Heatherfield Drive Soudertown, PA 18964 / US | [2008/16] | Representative(s) | Fisher, Adrian John, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [2008/16] | Fisher, Adrian John, et al CARPMAELS & RANSFORD 43-45 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 05782009.4 | 02.08.2005 | [2008/16] | WO2005US27568 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007030089 | Date: | 15.03.2007 | Language: | EN | [2007/11] | Type: | A1 Application with search report | No.: | EP1910353 | Date: | 16.04.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.03.2007 takes the place of the publication of the European patent application. | [2008/16] | Search report(s) | International search report - published on: | EP | 15.03.2007 | Classification | IPC: | C07D451/02, A61K31/46, A61P29/00 | [2008/16] | CPC: |
C07D451/02 (EP,KR,US);
A61K31/46 (KR);
A61P1/04 (EP);
A61P11/00 (EP);
A61P13/02 (EP);
A61P25/04 (EP);
A61P25/16 (EP);
A61P25/24 (EP);
A61P25/30 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/16] | Extension states | AL | 02.03.2007 | BA | 02.03.2007 | HR | 02.03.2007 | MK | 02.03.2007 | YU | 02.03.2007 | Title | German: | TRICYCLISCHE DELTA-OPIOID-MODULATOREN | [2008/16] | English: | TRICYCLIC DELTA- OPIOID MODULATORS | [2008/16] | French: | MODULATEURS D OPIOÏDES DELTA TRICYCLIQUES | [2008/16] | Entry into regional phase | 02.03.2007 | National basic fee paid | 02.03.2007 | Designation fee(s) paid | 02.03.2007 | Examination fee paid | Examination procedure | 02.03.2007 | Examination requested [2008/16] | 06.03.2007 | Amendment by applicant (claims and/or description) | 13.05.2009 | Despatch of a communication from the examining division (Time limit: M06) | 23.11.2009 | Reply to a communication from the examining division | 09.09.2011 | Despatch of a communication from the examining division (Time limit: M04) | 20.01.2012 | Application deemed to be withdrawn, date of legal effect [2012/32] | 08.03.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/32] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.05.2009 | Fees paid | Renewal fee | 02.03.2007 | Renewal fee patent year 03 | 31.03.2008 | Renewal fee patent year 04 | 12.08.2009 | Renewal fee patent year 05 | 17.08.2010 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.08.2011 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO0166543 (ORTHO MCNEIL PHARM INC [US]) [A] 1-118* claim - *; | [A]US2003181447 (BOYD ROBERT E [US], et al) [A] 1-118 * claim -; table 1 *; | [X]WO2005003131 (JANSSEN PHARMACEUTICA NV [BE], et al) [X] 1-118 * the whole document * |